EDESA BIOTECH, INC. Proceeds from Issuance of Private Placement
EDESA BIOTECH, INC. (EDSA) reported Proceeds from Issuance of Private Placement of $6.48 million for the 12-month period ending 2014-08-31, per its 10-K filed 2014-11-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2015-12-14
- EDESA BIOTECH, INC. proceeds from issuance of private placement for fiscal 2014 was $6.48M, a 20.47% decline from fiscal 2013.
- EDESA BIOTECH, INC. proceeds from issuance of private placement for fiscal 2013 was $8.15M.
- EDESA BIOTECH, INC. proceeds from issuance of private placement for fiscal 2012 was $0.00.
| Period end | Proceeds from Issuance of Private Placement 1 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|
| 2014-08-31 | $6.48M 10-K · filed 2014-11-21 | |
| 2013-09-30 | $12.00M 10-K · filed 2015-12-14 | |
| 2013-08-31 | $8.15M 10-K · filed 2014-11-21 | |
| 2012-08-31 | $0.00 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |